Pharmaceutical companies have close relations with anti-doping agencies

Today a lot of pharmaceutical companies are ready to collaborate with anti-doping officials in their war on administration of forbidden medications in sports. It sounds strange but it is the reality. In fact, if you review the fate of EPO, you can understand why pharmaceutical companies agree to support efforts of anti-doping officials. EPO is really an efficient remedy for treatment of anemia. A lot of persons with anemia that have taken EPO have been treated. But what do you think while hearing about this drug? Almost every person associates this remedy just with doping in sports. This medication has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated just with cheating, shame, etc. Looking at this situation, drug manufacturers try to “defend” their drugs from the similar fate. That’s why they cooperate with anti-doping officers.
Although certain pharmaceutical companies began to collaborate with anti-doping agencies long ago, sometimes there were several problems between them. Anti-doping officials criticized some drug manufacturers for their links to doping.
Nowadays relations between anti-doping officers and pharmaceutical companies are better. Pharmaceutical companies share detailed information about new drugs with anti-doping officials. It is valuable information for development of detection tests for these medicines. While anti-doping officials find out how preparations are manufactured, how they pass into body, how they work in the body, they can introduce more effectual tests for these preparations.
For example, the pharmaceutical company Roche that developed the medication CERA helped anti-doping officers to develop a detection test for it. Later other companies followed the example of Roche. The drug manufacturer GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping officers and big pharmaceutical companies become closer, smaller drug manufacturers started to collaborate with anti-doping officers too. While earlier drug manufacturers haven’t wanted to discuss about their relations with anti-doping officials openly, nowadays they don’t fear to announce about this condition.